MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

Although specific microRNA (miRNA) signatures in classical Hodgkin lymphoma (cHL) have been proposed, their relationship with clinical outcome remains unclear. Despite treatment advances, a substantial subset of patients with advanced cHL are refractory to standard therapies based on adriamycin and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Haematol
Hauptverfasser: Sánchez-Espiridión, Beatriz, Martín-Moreno, Ana M., Montalbán, Carlos, Figueroa, Vianihuini, Vega, Francisco, Younes, Anas, Medeiros, L. Jeffrey, Alvés, Francisco J., Canales, Miguel, Estévez, Mónica, Menarguez, Javier, Sabín, Pilar, Ruiz-Marcellán, María C., Lopez, Andrés, Sánchez-Godoy, Pedro, Burgos, Fernando, Santonja, Carlos, López, José L., Piris, Miguel A., Garcia, Juan F.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291117/
https://ncbi.nlm.nih.gov/pubmed/23725219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12390
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge